HAND MASSAGE AFTER ACUTE CORONARY SYNDROME

Sponsor
TC Erciyes University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06077175
Collaborator
(none)
120
2
2.9

Study Details

Study Description

Brief Summary

Patients suffering from Acute coronary syndrome may be hospitalized again in a shorter time than expected, and after being discharged, they may live within the limitations imposed by the disease until the end of their lives. This situation causes anxiety in individuals. Today, various methods are used to reduce high levels of anxiety. Massage is the planned and purposeful application of touch and is the most common, most important and oldest complementary treatment used in traditional practices. It is also thought that the comfort levels of individuals experiencing ACS will increase by reducing their anxiety. This study was planned to determine the effect of hand massage applied to patients with ACS on comfort, anxiety level and vital signs.

Condition or Disease Intervention/Treatment Phase
  • Other: hand massage group
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
EFFECT OF HAND MASSAGE ON PATIENTS AFTER ACUTE CORONARY SYNDROME ON THE COMFORT AND ANXIETY LEVEL
Anticipated Study Start Date :
Nov 30, 2023
Anticipated Primary Completion Date :
Dec 30, 2023
Anticipated Study Completion Date :
Feb 27, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: intervention group

Other: hand massage group
Each individual will receive a 10-minute hand massage, 5 minutes for each hand. Since the speed and number of repetitions of the massage movements should be at normal frequency, the massage will be performed at a speed that does not disturb the individual, is not stimulating and has a calming effect, and will not tire the practitioner. In the massage, effleurage (stroking) and friction (circular rubbing) movements will be used, which have a circulation-supporting and tissue-relaxing effect. Evaluations will be made within 30 minutes after the hand massage.

No Intervention: Control group

Outcome Measures

Primary Outcome Measures

  1. Beck Anxiety Scale [It will be done before the massage application, 24 hours after arrival in the intensive care unit.]

    It is a self-rating scale used to determine the frequency of anxiety symptoms experienced by individuals.

  2. Beck Anxiety Scale [It will be applied on the 4th day at the end of the application.]

    It is a self-rating scale used to determine the frequency of anxiety symptoms experienced by individuals.

Secondary Outcome Measures

  1. General Comfort Scale [It will be done before the massage application, 24 hours after arrival in the intensive care unit.]

    It is used to determine the comfort level of patients.

  2. General Comfort Scale [It will be applied on the 4th day at the end of the application.]

    It is used to determine the comfort level of patients.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients experiencing Acute Coronary Syndrome for the first time,

  • Anxiety score of 16 and above (moderate and severe anxiety)

  • 18 years and above,

  • No psychiatric disease,

  • Patients who do not have communication problems and are competent to answer all questions,

Exclusion Criteria:
  • Patients with uncontrolled Diabetes mellitus

  • Patients who cannot communicate and have confusion,

  • Those who have any limb, vascular problem or wound that prevents hand massage,

  • Thrombophlebitis, occlusive arterial disease, fever etc. Those for whom massage therapy is inconvenient due to illness,

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • TC Erciyes University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Özlem Ceyhan, Teaching staff, TC Erciyes University
ClinicalTrials.gov Identifier:
NCT06077175
Other Study ID Numbers:
  • AKSHAND
First Posted:
Oct 11, 2023
Last Update Posted:
Oct 13, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Özlem Ceyhan, Teaching staff, TC Erciyes University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 13, 2023